Furthermore, it was also revealed that IGF2BP3‐dependent m6A modification of USP49 enhances autophagy by stabilizing SIRT1 via its deubiquitination, helping RB cells survive under CBP treatment. The gene discussed is IGF2BP3; the disease is retinoblastoma.